Home About Us Services Industry Report Store Resources Contact us
IntelEvoResearch

Medical Devices

Medical Devices

Global AI in Remote Patient Monitoring Market Size, Share & Analysis By Monitoring Device Type (Wearable, Implantable, Stationary), By Component (Hardware, Software, Services), By Technology (Machine Learning, Natural Language Processing, Computer Vision), By Application (Chronic Disease Management, Geriatric Care Management, Sleep Apnea Monitoring, Fitness Monitoring) Industry Dynamics & Forecast 2025–2034

The Artificial Intelligence (AI) in Remote Patient Monitoring (RPM) Market is valued at USD 3.9 billion in 2024 and is projected to reach approximately USD 32.4 billion by 2034, growing at a powerful CAGR of around 24.8% from 2025–2034. The surge reflects rising adoption of AI-enabled wearables, predictive health alerts, and chronic-care monitoring platforms across global healthcare systems. With hospitals prioritizing virtual-first models and payers expanding reimbursement for continuous monitoring, AI-driven RPM is becoming a cornerstone of preventive and personalized care. Increasing integration of digital biomarkers, real-time analytics, and edge-AI devices is further driving visibility and engagement on professional and social platforms.

4/5
( 177 )
| Pages : 210 | US $3350 Onwards | Published Date : 2025-12-03 | Report Code : IR338

Global Nuclear Medicine Market Size, Share & Analysis By Product Type (Diagnostics, Therapeutics), By Application (Cardiology, Oncology, Neurology, Thyroid, Lymphoma, Bone Metastasis, Urology, Pulmonary Scans, Endocrine Tumor, Other), By End-user (Hospitals, Diagnostic Centers), Technology Advancements, Regulatory Outlook & Forecast 2025–2034

The Nuclear Medicine Market size is expected to be worth around USD 54.3 Billion by 2034, from USD 20.8 Billion in 2024, growing at a CAGR of 11.12% during 2025–2034. This growth trajectory underscores the critical role nuclear medicine plays in modern healthcare, particularly in addressing the global rise in chronic diseases such as cancer and cardiovascular disorders. In 2024, North America accounted for more than 43.5% of the market, valued at USD 8.4 Billion, supported by strong healthcare infrastructure, high adoption of advanced imaging technologies, and significant research investments.

4/5
( 177 )
| Pages : 210 | US $3350 Onwards | Published Date : 2025-11-17 | Report Code : IR282

Global Ophthalmic Equipment Market Size, Share, Analysis Report By Type(Diagnostic & Monitoring Devices, Surgical Devices, Vision Care Products), Deployment(Hospital-based, Ambulatory Surgical Centers), Application(Cataract Surgery, Glaucoma Treatment), End-User(Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Research & Academic Institutes) Industry Region & Key Players-Industry Segment Overview, Market Dynamics, Competitive Strategies, Trends & Forecast 2025-2034

The Ophthalmic Equipment Market size is expected to be worth around USD 105.0 Billion by 2034, from USD 58.5 Billion in 2024, growing at a CAGR of 6.0% during the forecast period from 2024 to 2034. The ophthalmic equipment market encompasses a wide range of medical devices and instruments used for the diagnosis, treatment, and management of various eye conditions and vision disorders. This rapidly expanding market includes diagnostic devices like ophthalmoscopes, refractometers, and OCT scanners, as well as surgical instruments such as phacoemulsification systems, ophthalmic lasers, and vitreoretinal instruments. It also covers vision care products like contact lenses and eyeglasses manufacturing equipment.

4/5
( 177 )
| Pages : 225 | US $3575 Onwards | Published Date : 2025-07-14 | Report Code : IR113

➮ Industries

Why IntelEvoResearch

100%

Customer
Satisfaction

24x7+

Availability - we are always
there when you need us

200+

Fortune 50 Companies trust
IntelEvoResearch

80%

of our reports are exclusive
and first in the industry

100%

more data
and analysis

1000+

reports published
till date

Trusted by Clients across world

IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch
IntelEvoResearch